அரசு ஆஃப் இந்தியா துறை மருந்துகள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from அரசு ஆஃப் இந்தியா துறை மருந்துகள். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In அரசு ஆஃப் இந்தியா துறை மருந்துகள் Today - Breaking & Trending Today

Aarti Drugs' unit gets approval under pharma PLI scheme

Aarti Speciality Chemicals, a wholly-owned subsidiary of Aarti Drugs has received an approval accorded under Production Linked Incentive (PLI) scheme for pharmaceutical sector.
Government of India s Department of Pharmaceuticals under the Ministry of Chemicals and Fertilizers recently launched a Production Linked Incentive (PLI) scheme to promote domestic manufacturing by incentivising pharmaceutical manufacturers to set-up greenfield projects in India with a minimum domestic value addition in four different target segments (Two in Fermentation based - at least 90% and Two in the Chemical Synthesis based - at least 70%) with a total outlay of Rs 6,940 crore.
The objective of the scheme is achieving self-reliance and reducing import dependence in these critical Key Starting Materials (KSMs)/ Drug Intermediates/ Active Pharmaceutical Ingredients (APIs) in the country. The tenure of the scheme is from FY21 to FY30. ....

Adhish Patil , Government Of India Department Pharmaceuticals , Ministry Of Chemicals , Aarti Speciality Chemicals , Aarti Drugs , Production Linked Incentive , Chemical Synthesis , Key Starting Materials , Active Pharmaceutical Ingredients , Speciality Chemicals , Target Segment , Key Chemical Synthesis Based , Drug Intermediates , Chief Financial Officer , Pharma Intermediates , Capital Market , Pharmaceutical Industry In China , Pharmaceuticals Policy , Pharmacy In China , Science And Technology In The Peoples Republic Of China , Chemical Substance , Physical Sciences , Natural Sciences , Companies Based In , அரசு ஆஃப் இந்தியா துறை மருந்துகள் , அமைச்சகம் ஆஃப் இரசாயனங்கள் ,

Aarti Drugs' unit benefits from Govt.'s PLI Scheme

Aarti Speciality Chemicals, a wholly-owned subsidiary of Aarti Drugs (Aarti Drugs), stands out to be one of the beneficiaries of the Government of India s recently approved Production Linked Incentive (PLI) for the Pharmaceutical Sector.
Government of India s Department of Pharmaceuticals under the Ministry of Chemicals and Fertilizers recently launched a Production Linked Incentive (PLI) Scheme to promote domestic manufacturing by incentivising pharmaceutical manufacturers to set-up greenfield projects in India with a minimum domestic value addition in four different target segments (Two in Fermentation based - at least 90% and Two in the Chemical Synthesis based - at least 70%) with a total outlay of Rs. 6,940 crores. The objective of the scheme is achieving self-reliance and reducing import dependence in these critical Key Starting Materials (KSMs)/ Drug Intermediates/ Active Pharmaceutical Ingredients (APIs) in the country. ....

Government Of India Department Pharmaceuticals , Ministry Of Chemicals , Aarti Speciality Chemicals , Aarti Drugs , Production Linked Incentive , Chemical Synthesis , Key Starting Materials , Active Pharmaceutical Ingredients , Target Segments , Speciality Chemicals , Target Segment , Key Chemical Synthesis Based , Drug Intermediates , Capital Market , Indian Films , Pharmaceuticals Nec , Government Of Indias Department Pharmaceuticals , Government Of India , Pharmaceutical Manufacturers , Ministry Of Chemicals And Fertilizers , அரசு ஆஃப் இந்தியா துறை மருந்துகள் , அமைச்சகம் ஆஃப் இரசாயனங்கள் , ஆர்த்தி சிறப்பு இரசாயனங்கள் , ஆர்த்தி மருந்துகள் , ப்ரொடக்ஶந் இணைக்கப்பட்டுள்ளது ஊக்கத்தொகை , இரசாயன தொகுப்பு ,

Aarti Speciality Chemicals Limited receives an approval accorded under PLI Scheme for Pharmaceutical Sector

Aarti Speciality Chemicals Limited receives an approval accorded under PLI Scheme for Pharmaceutical Sector
Posted On:
2021-03-06 04:25:29
(Time Zone: Arizona, USA)
Aarti Speciality Chemicals Limited (ASCL), a wholly-owned subsidiary of Aarti Drugs Limited (Aarti Drugs), stands out to be one of the beneficiaries of the Government of India s recently approved Production Linked Incentive (PLI) for the Pharmaceutical Sector.
Government of India s Department of Pharmaceuticals under the Ministry of Chemicals and Fertilizers recently launched a Production Linked Incentive (PLI) Scheme to promote domestic manufacturing by incentivising pharmaceutical manufacturers to set-up greenfield projects in India with a minimum domestic value addition in four different target segments (Two in Fermentation based - at least 90% and Two in the Chemical Synthesis based - at least 70%) with a total outlay of Rs. 6,940 crores. The objective of the scheme is achieving self-relian ....

United States , Adhish Patil , Atmanirbhar Bharat , Government Of India Department Pharmaceuticals , Aarti Drugs Limited , Aarti Speciality Chemicals , Aarti Speciality Chemicals Limited , Ministry Of Chemicals , Aarti Drugs , Speciality Chemicals Limited , Time Zone , Production Linked Incentive , Chemical Synthesis , Key Starting Materials , Drug Intermediates , Active Pharmaceutical Ingredients , Target Segments , Target Segment , Key Chemical Synthesis Based , Chief Financial Officer , Drugs Limited , Balance Sheet , Mutual Funds , New Issue , Public Issue , Rights Issue ,